PubRank

Tri Q Nguyen

Author PubWeight™ 23.03‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Reversibility of structural and functional damage in a model of advanced diabetic nephropathy. J Am Soc Nephrol 2013 1.30
2 Fidelity and evolution of recurrent FSGS in renal allografts. J Am Soc Nephrol 2008 1.11
3 Oxidative stress in obstructive nephropathy. Int J Exp Pathol 2010 1.10
4 BMP signaling and podocyte markers are decreased in human diabetic nephropathy in association with CTGF overexpression. J Histochem Cytochem 2009 1.04
5 Loss of endogenous bone morphogenetic protein-6 aggravates renal fibrosis. Am J Pathol 2011 1.03
6 Targeting podocyte-associated diseases. Adv Drug Deliv Rev 2010 1.01
7 Reduced Cx43 expression triggers increased fibrosis due to enhanced fibroblast activity. Circ Arrhythm Electrophysiol 2012 0.98
8 Healthy bone marrow cells reduce progression of kidney failure better than CKD bone marrow cells in rats with established chronic kidney disease. Cell Transplant 2012 0.97
9 Connective tissue growth factor (CTGF/CCN2) ELISA: a novel tool for monitoring fibrosis. Biomarkers 2011 0.97
10 Differential regulation of E-cadherin and alpha-smooth muscle actin by BMP 7 in human renal proximal tubule epithelial cells and its implication in renal fibrosis. Am J Physiol Renal Physiol 2009 0.92
11 Renal proximal tubular dysfunction is a major determinant of urinary connective tissue growth factor excretion. Am J Physiol Renal Physiol 2010 0.90
12 The Caenorhabditis elegans NR4A nuclear receptor is required for spermatheca morphogenesis. Dev Biol 2007 0.89
13 Direct visualization of Smad1/5/8-mediated transcriptional activity identifies podocytes and collecting ducts as major targets of BMP signalling in healthy and diseased kidneys. J Pathol 2011 0.87
14 Hemizygous deletion of CTGF/CCN2 does not suffice to prevent fibrosis of the severely injured kidney. Matrix Biol 2012 0.85
15 A functional NR4A nuclear receptor DNA-binding domain is required for organ development in Caenorhabditis elegans. Genesis 2010 0.83
16 Modulation of TGF-β/BMP-6 expression and increased levels of circulating smooth muscle progenitor cells in a type I diabetes mouse model. Cardiovasc Diabetol 2010 0.82
17 Effects of antiproteinuric intervention on elevated connective tissue growth factor (CTGF/CCN-2) plasma and urine levels in nondiabetic nephropathy. Clin J Am Soc Nephrol 2011 0.81
18 Preclinical biomarkers for a cyclin-dependent kinase inhibitor translate to candidate pharmacodynamic biomarkers in phase I patients. Mol Cancer Ther 2009 0.81
19 Connective tissue growth factor is associated with a stable atherosclerotic plaque phenotype and is involved in plaque stabilization after stroke. Stroke 2010 0.80
20 The CTGF -945GC polymorphism is not associated with plasma CTGF and does not predict nephropathy or outcome in type 1 diabetes. J Negat Results Biomed 2011 0.79
21 Intervention in growth factor activated signaling pathways by renally targeted kinase inhibitors. J Control Release 2008 0.78
22 Involvement of connective tissue growth factor in human and experimental hypertensive nephrosclerosis. Nephron Exp Nephrol 2010 0.78
23 Amelioration of anti-Thy1-glomerulonephritis by PPAR-gamma agonism without increase of endothelial progenitor cell homing. Am J Physiol Renal Physiol 2007 0.77
24 Effect of GFR on plasma N-terminal connective tissue growth factor (CTGF) concentrations. Am J Kidney Dis 2012 0.77
25 Compensatory growth of congenital solitary kidneys in pigs reflects increased nephron numbers rather than hypertrophy. PLoS One 2012 0.77
26 Does high or low urinary connective tissue growth factor predict CKD? Am J Kidney Dis 2011 0.75